Loading...
An EU-wide approach to HTA: An irrelevant development or an opportunity not to be missed?
An EU-wide cooperation on HTA has been proposed recently by the European Commission, focusing on relative effectiveness assessment (REA) for pharmaceuticals and medical devices. This cooperation is operationalised through a proposal for a regulation. While a good step in the right direction, this HT...
Na minha lista:
| Udgivet i: | Eur J Health Econ |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer Berlin Heidelberg
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6438931/ https://ncbi.nlm.nih.gov/pubmed/30868380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10198-019-01037-2 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|